Hemfosa Fastigheter divests residential properties

Hemfosa is divesting five residential properties, which also include certain commercial operations, in Gävle to M2 Gruppen. The transaction will contribute to the continued streamlining of the property portfolio according to the strategy of focusing on community service properties. Hemfosa has signed an agreement to divest the residential properties Gävle Norr 22:3, Norr 34:2, Norr 35:1, 35:4 and Norr 36:1, totaling 14,256 sqm of leasable area at an underlying property value of MSEK 170. The properties have a leasing rate of 85 percent and the tenants mainly comprise residential tenants, as well as certain commercial operations on the ground floor. Annual rental income amounts to approximately MSEK 13. The transaction is being carried out through the sale of Hemfosa’s share in two property-owning limited partnership companies. The buyer is the M2 Gruppen property company. The properties will change hands on February 1, 2016. “The purpose of the sale is to divest properties in non-prioritized segments in a strong transaction market. We are continuing to streamline our property portfolio and move toward community service properties in line with our stated strategy,” says Stina Lindh Hök, Head of Transactions at Hemfosa Fastigheter. For further information, please contact: Stina Lindh Hök, Head of Transactions, stina.lindh.hok@hemfosa.se, mobile: +46 70 577 18 85, switchboard: +46 8 448 04 80. About Hemfosa Fastigheter Hemfosa is a Swedish property company with a well-balanced and geographically diversified property portfolio focusing on a high proportion of community service properties with the State and municipalities as the largest tenants. This provides stable cash flows and a healthy yield. In order to create value, Hemfosa also aims to actively participate in the transaction market. At September 30, 2015, Hemfosa owned commercial properties in Sweden with a total property value of approximately SEK 30.8 billion, including the company’s share of the property value in joint ventures. The company’s common share has been listed since March 2014, and the preference share since December 2014, both on Nasdaq Stockholm. Read more at www.hemfosa.se.